Read/Post Comments (0) | Recommended this article (0)
Please login to Zacks.com or register to post a comment.
Zacks' 7 Best Stocks
for June, 2013
FREE Report for Zacks.com
Visitors Only
Visitors Only
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
- Latest News
- Most Popular
- Winning ETF Strategies for the Second Half
- RTI: What Will the Fed Do Wednesday?
- RTI: Hey Homies - BULL Is the Word!
- Tech Roundup: GOOG Shows Mettle, AAPL in Freefall
- Home-Run Retailers
- Are Housing ETFs Back on Track?
- Buy Your Favorite Brands with These 3 Stocks
- What's a Global Investor to Do?
- 5 Careful Ways to Win with Options
- AWS 6/17: The Fed in Focus This Week
- PFP 6/17: Why Ask Why?
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
Zacks #1 Stocks on the Move 06/17/2013
| Company Name | Symbol | %Change |
|---|---|---|
| GLOBAL GEOPH | GGS | 7.79% |
| STAAR SURGIC | STAA | 6.23% |
| KAPSTONE PAP | KS | 6.14% |
| HORNBECK OFF | HOS | 5.99% |
| ANIKA THERAP | ANIK | 5.55% |
Quick Links
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Prudent capital management, expanded share repurchase plan and affirmation of a strong financial strength rating point to decent long-term growth. Employers engaged in hazardous industries pay substantially higher than average rates for workers compensation insurance due to the inherent workplace danger. Amerisafe has a history of profitable underwriting in these industries.
Our six-month target price of $33.00 per share equates to about 19.1x our earnings estimate for 2012. With no dividend supplement, this target price implies a total expected of 18.3% over that period, which is consistent with our Outperform recommendation.
Get the full Analyst Report on AMSF - FREE